3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
3
Terminated
2
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Gynecologic
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Interventions
Cyclophosphamide
241
Radiotherapy
217
Gemcitabine
187
Cisplatin
185
Carboplatin
182
Docetaxel
166
Bevacizumab
166
Paclitaxel
144
Capecitabine
142
Rituximab
141
pembrolizumab
140
Nivolumab
126
Oxaliplatin
124
Dexamethasone
122
Fluorouracil
113
fludarabine
104
Radiosurgery
101
Doxorubicin
99
fludarabine phosphate
97
Irinotecan
96
Etoposide
95
Lenalidomide
93
Cytarabine
92
Magnetic Resonance Spectroscopy
90
Radiation
89
Filgrastim
89
Leucovorin
88
Bortezomib
86
Cetuximab
80
Pemetrexed
79
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
OTHER
×
Pharmacokinetics
×
Clear all
NCT04861181
2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4
Terminated
12 enrolled
NCT01855061
2018-03-09
CPCT-01
UMC Utrecht
Terminated
79 enrolled